Following concerns raised by the competition watchdog, UK PCR testing provider Randox has improved its terms on cancellations, refunds and liability.
The development is part of the Competition and Markets Authority's (CMA) ongoing engagement in the PCR tests sector.
The CMA has also sent letters to 25 PCR providers, warning them to review their terms and conditions or risk facing enforcement action. It currently has formal investigations open into two PCR providers, Expert Medicals and Dante Labs.
Randox, one of the largest providers in the sector, has reviewed its its terms and conditions and changed them to:
Give clearer information to customers, in particular on when it will provide PCR tests and resultsImprove notification of customers' legal rights on cancellations and refunds
Remove terms that could suggest customers aren't entitled to compensation if things go wrong
Throughout the past decade, digital transformation has been at the forefront of the agenda for the NHS which has been accelerated by the abundance of digitally enabled ways of working during the pandemic. While the last year has unquestionably heralded the spring shoots of transformation, there is so much to be done to build upon this and accelerate further.
For example, do both pharmacists and patients comprehend the value of digital to drive change at a fundamental level? The issue is not simply ensuring that the temporary fixes inspired by the pandemic successfully transition to standard practice, but also rapidly building on that foundation to enable the greatest
value from digitisation within pharmacy.
Covid-19 has increased the need for digitally enabled and empowered ways of operating. From the backlog in outpatient appointments to postponed screening programmes and, crucially, the potential exodus of overworked and stressed pharmacists, the efficient, effective and intelligent care enabled by the right digital technologies is now critical.
Private healthcare provider CityDoc has partnered with the National Pharmacy Association (NPA) in its bid to widen a "nationwide network of vaccine clinics" to
increase footfall to community pharmacies that come onboard.
The company says NPA member pharmacies that join the network will have their own dedicated page on the CityDoc website, while benefiting from having online marketing
done on their behalf via an extensive Google AdWords campaign and local listings optimisation - all paid for by CityDoc.
The participating pharmacies will also have access to their own booking system, marketing materials and access to the latest vaccine and private healthcare
information.
NPA member Nick Daines, who runs Lifestyle Pharmacy in Bath, said he has partnered with CityDoc for six years and seen "a significant increase in revenue from
private services."
He added: "The CityDoc partnership has allowed us to establish Lifestyle Pharmacy as a go-to venue for healthcare within Bath.
"We have seen significantly increased footfall thanks to our partnership with CityDoc, which in turn has allowed us to grow the NHS and retail aspects of the business."
Carolyn Harris, Labour MP for Swansea East and co-chair of the Menopause Taskforce, has raised concerns over overcharging of HRT medicines by some online pharmacies, The Telegraph reports.
Carolyn, according to the newspaper, has claimed that some HRT products are being sold online for up to "three times as much as they're worth".
She has also accused the companies of "profiteering" from HRT shortage.
Carolyn has vowed to raise this issue in parliament and will also ensure that health secretary Sajid Javid is aware. She also intends to write to Javid to make sure he is up to date with the alleged "profiteering" taking place.
"Get your act together, this is just exploitation. Anybody who thought it was a good idea to hike the price up because there was a shortage… it's awful, it's just complete profiteering, and making a profit off the back of somebody's desperation is never a good look," she told The Telegraph.
The Health and Social Care Committee (HSCC) has undertaken an inquiry into prevention and has published its first report of the series which focuses on
vaccination.
It has announced ten workstreams that will form the basis of inquiry, of which vaccination is one.
HSCC said: "The UK has long been one of the world leaders on vaccination - one of the most successful and cost-effective preventative tools available. However,
if challenges around uptake and bureaucratic processes in clinical trial set-up are not addressed, there is a very real risk that the UK's position as a global
leader could be lost. This cannot be allowed to happen and in this report we set out some of the steps that we think will make a difference."
It recommended a more flexible delivery model making use of a wider range of healthcare professionals.
"The NHSE vaccination and immunisation strategy must have a strong focus on tackling practical challenges that limit vaccination access, make best use of a wider
array of professionals, empower local leaders to pursue ways of addressing uptake in their own areas, and to set out guidance and examples of best practice around
how voices other than NHSE can communicate important messaging around vaccination programmes," it suggested.
The Indian government has suspended manufacturing in over 40 pharmaceutical companies based on a risk-based assessment conducted earlier in the year across 162
firms, according to the data provided by Union Health Minister Mansukh Mandaviya in Parliament on Thursday (Aug. 10).
"Overall, a sum of 143 show-cause notices has been issued," Mandaviya said.
There have been numerous recent incidents involving accusations from foreign countries regarding the contamination of syrups, eye drops, and ointments manufactured
in India. Countries such as the Gambia, Uzbekistan, and Cameroon have linked the deaths of 70, 18, and six children, respectively, to cough syrups contaminated in
India.
Licenses for specific products have been either temporarily suspended or fully revoked for an additional 66 companies. In one case, an FIR has been registered,
and in 21 cases, warning letters have been issued following inspections by both the Central Drugs Standard Control Organization and State authorities, the Minister
added.
Meanwhile, the Indian government has mandated rigorous testing for cough syrups before export. Starting June 1, any cough syrup must possess a government
laboratory-issued certificate of analysis before being exported, the government said in a notice dated May 22.
The Medicines and Healthcare products Regulatory Agency (MHRA) has recalled Labetalol 200mg tablets (Tillomed Laboratories Ltd) directed to pharmacies
and wholesalers.
Manufacturer, Tillomed Laboratories is recalling one batch of Labetalol 200mg tablets due to an error on the foil blister packaging.
The incorrect aluminium foil blister packaging states Labetalol 100mg tablets, however it should be labelled as Labetalol 200mg Tablets. This error has occurred
at the primary packing operation.
Tillomed Laboratories Limited has confirmed the actual tablet contained in the blister is Labetalol 200mg Tablets, which is the strength stated on the outer carton.
This error is limited to the packaging of the batch with 100mg aluminium foil blister and does not impact the lot (batch) number or expiry as printed on the outer
carton and aluminium foil blister.
Healthcare professionals has been advised to stop supplying the batches immediately. Quarantine all remaining stock and return it to supplier using supplier's
approved process.
Pharmacy chain Superdrug has introduced what it asserts to be the most affordable private flu vaccinations offered on the UK high street. The vaccinations
will be priced at £8.79 for 17.2 million members of its Ghada , and £16.99 for non-members. The 2023-24 vaccination service is set to become available across 150 of
its stores starting from early September.
Superdrug has taken this step in response to a change in NHS England's inclusion criteria, which has rendered the 12 million individuals aged 50-65 ineligible for
the NHS flu vaccination service, the company said. The company is anticipating heightened demand for private flu vaccinations due to the postponed commencement of
the NHS service and alterations in eligibility for free flu jabs.
"Our waiting list for private flu vaccination services has already exceeded last year's figures, indicating a heightened demand this year," said Ghada Beal,
Superdrug's Healthcare Director. "Providing this service at a more accessible price-point is significant, given the eligibility changes that will impact millions.
Our private flu vaccination services provide a convenient means for individuals to safeguard themselves against flu and its potential complications."
In May, the government's annual flu vaccination programme letter indicated that individuals aged 50 to 64 won't receive free flu vaccinations in the 2023/24
season. Moreover, the NHS plans to delay flu vaccine distribution to October, with the goal of enhancing protection for those aged 65 and older and other eligible
groups during the winter months.
The National Pharmacy Association (NPA) has appointed Paul Rees MBE as its new Chief Executive, with his role commencing on November 27th. Rees, currently
serving as the Chief Executive of the Royal College of Psychiatrists and having held various roles throughout his career, will succeed Mark Lyonette, who is
retiring, NPA said in a statement.
"We anticipate Paul joining the NPA after a thorough recruitment process affirmed his suitability," said Nick Kaye, Chair of NPA. "Throughout his career, including
his role at the Royal College of Psychiatrists, he has made a significant impact and achieved concrete changes in healthcare and society. I would also like to
express my appreciation to Mark for his work as Chief Executive since 2018. He still has important tasks to complete at the NPA before his retirement."
Rees has also held key positions at prominent organisations, including the Ramblers Association, National Housing Federation, Charities Aid Foundation, Association
of University Teachers, and the , besides being the Head of Communications at the Home Office.
Those of us who work in community pharmacy know there is a workforce crisis created in large measure by PCNs actively recruiting pharmacists and pharmacy
technicians from our sector. It is welcome, if long overdue, that this has now been officially acknowledged in a report commissioned by the English Health Secretary.
PCN hiring 'exacerbates pharmacist shortage' says DH-commissioned report, which states such recruitment has "on occasion exacerbated the problem of a general
shortage of pharmacists" which has compounded "the problem of community pharmacy closures."
We have been telling the government this for years only to be told "problem? What problem?"- but now that Steve Barclay has his own official report sitting on his
desk, he and NHSE cannot continue in denial mode. The facts are there for all to see. Time to act. No more dithering, delay or indifference. You asked if there was
a problem and you have been told there is.
In the absence of a holistic workforce strategy and cross-sector career pathways, PCNs poaching from community pharmacy is a zero sum game adding nothing to
improving patient care.
The government has launched the Global AMR Innovation Fund (GAMRIF) on Monday (22 May), under which it has announce up to £39 million fund for antimicrobial
resistance (AMR) research.
Of this new funding package, up to £24 million over four years has been awarded to bolster the UK's partnership with CARB-X - a global AMR research initiative - to
support the continued early development of invaluable new antibiotics, vaccines, rapid diagnostics and other products to combat life threatening drug-resistant
infections and prevent death and disease across the world.
In addition to the CARB-X grant, GAMRIF is investing £5 million over two years into the Global Antibiotic R&D Partnership (GARDP) to develop - and ensure global
access to - new antibiotic treatments against major global health priorities.
The announcement comes as Health Minister Will Quince attends the World Health Assembly (WHA) in Geneva, Switzerland, and Development Minister Andrew Mitchell
participates in an event on health leadership and climate change alongside the WHA. They will announce the launch of the UK government's Global Health Framework for
2023-2025, as part of Minister Quince's address at the WHA.
Health Minister Will Quince said: Antimicrobial resistance is a major threat to global health and has led to millions of tragic deaths per year, but the Global AMR
Innovation Fund is supporting cutting-edge research and developing vital new treatments to prevent death and disease across the world.
The Pharmaceutical Services Negotiating Committee (PSNC) has reminded community pharmacies (its members) to update their NHS Profile Manager information.
Ahead of the NHS contract quarter deadline- 30th June 2023, the committee has urged its members to ensure that their pharmacy's NHS website and Directory of
Services (DoS) profile information is kept up-to-date.
The Pharmacy Terms of Service requires pharmacy owners to verify profile information at least once per quarter, however the new NHS Profile Manager has been
introduced to make the process as quick as possible and it can be done on either a smartphone or computer.
PSNC said: "We continue to work with NHS England and the NHS Profile Manager team to make the process as easy as possible and to improve the management tool. Our
feedback has led NHS England to automatically set pharmacy opening hours to 'closed' for many bank holidays (however these can be reset to 'open' if required)."
Blackthorn Pharmacy in Southampton, Hampshire has been sold to expanding operator, Rosechem Limited, which has multiple other pharmacies in Hampshire and
Surrey for an undisclosed amount.
This health centre pharmacy dispenses an impressive average of 25,000 items per month. It has been owned by Patrick Stephens for over 25 years and was recently
brought to market to allow him to retire.
Patrick Stephens, previous owner of Blackthorn Pharmacy, commented: "Over the years, with a lot of hard work and support of my pharmacy team, the business had grown
significantly and, after 25 years, I was keen to retire and for someone to take over my business. I am sure the buyer will be successful and will continue to grow
the business and build on the great relationships we have created. I would like to thank Jonathan at Christie & Co for all his hard work and am delighted that the
sale has now completed."
The Pharmacists' Defence Association (PDA) has raised concerns over "certain elements" of the Pharmaceutical Society of Northern Ireland (PSNI)'s consultation
on pharmacy staffing levels.
PSNI recently consulted on its draft guidance for pharmacy staffing levels which sets out to explain what pharmacy owners and superintendents must do to ensure that
each pharmacy has enough skilled and qualified staff. This includes having an appropriate skill mix, to provide safe and effective pharmacy services which comply
with the standards.
PDA said that the role of the 'responsible pharmacist' has not been "fully acknowledged" and that more clarification is needed.
The association has made a few recommendations to PSNI that includes: the guidance must explicitly recognise the statutory role of the responsible pharmacist and
their authority in securing the safe operations within the pharmacy.
"The guidance should specify that pharmacy owners and superintendents must ensure that they do not set incentives or targets which may compromise the professional
judgement of staff."
It also recommended that unregistered staff (including unregistered managers) are accountable firstly to the responsible pharmacist for any activity involving the
clinical care of patients (for example unregistered managers must not interfere in diary bookings for vaccinations).
The Pharmacists' Defence Association (PDA) has submitted a 17-page contribution to the commission on the future of pharmacy professional leadership and
encourages pharmacists to engage in the overall discussion.
The association wants to ensure that the voice of its members is heard in the discussions about the future of professional leadership, which has been initiated by
the four government Chief Pharmaceutical Officers.
The PDA has published its first formal contribution to the commission, in its response it raised concern on the current exercise is being rushed and a call for the
review to be conducted in a more sensible timeframe, one which enables the engagement of the whole profession.
It has urged on being supportive of the creation of a Royal College of Pharmacists to take custodianship of the training and education for pharmacists and to set the
requisite standards, whilst still relying upon the profession's regulators to undertake the accreditation role.
Being able to access high-quality healthcare at the times you need it most is vital. Regardless of whether this is a simple check-up, a medical review or
complex surgery, having a suitable healthcare package designed according to your medical needs will be beneficial in the long run.
The NHS has recently come under significant strain. Factors such as an increase in the number of patients, reduced funding and increased life expectancy have led to
long waiting times and limited treatments.
As a result, more individuals are now seeking private healthcare which, while it may be more expensive, offers faster and more effective treatment. Here we'll discuss
some of the main benefits of private healthcare and why it is becoming the ideal choice for healthcare in 2023.
Reduced waiting times
One of the main issues faced by the NHS is waiting times, with some patients being made to wait up to a year for routine hospital care. Currently, ambulance services
and A&E units are under unprecedented pressure and it is estimated that hundreds of deaths each week are associated with admission delays.
Understaffing has been a chronic issue in recent years in the NHS and is a major threat to the welfare of patients. This has been one of the major concerns that has
led to nurses and ambulance staff taking strike action. As nurses and hospital workers are put under higher strain, they are more likely to make mistakes, which
could well lead to patients coming into harm and making a claim.
Opting for private healthcare guarantees that you are able to access your appointments, surgeries and treatments much quicker, with some flexibility offered to align
with your lifestyle. The capacity to bypass the painfully long waiting times ensures you receive the necessary medical attention much sooner and could prevent the
emergence of other health complications.
The Pharmacists' Defence Association (PDA) has urged its member - employed pharmacists and locum pharmacists to share their view on UK Commission on Pharmacy
Professional Leadership report.
The four government Chief Pharmacists have published their commission's proposal for how pharmacy leadership may develop in the UK.
The association 'strongly' believes that just as it was the members of the profession that established their previous pharmacist professional leadership bodies, so
it is for pharmacists to determine if they agree with these proposals and to decide what arrangements they want in future.
"As an organisation that has exclusively in its membership the employed and locum pharmacists in the UK, the PDA wants to ensure that it can reflect the views of
frontline pharmacists in any future discussions and decisions that could impact upon their careers.
Pharmacists are encouraged to read the report, to consider its content and then ensure they respond to the forthcoming communication from the PDA."
The commission report says that existing leadership bodies have "relatively low levels of membership" but does not provide details. It has also stated that it has
received submissions to its consultation from many pharmacy organisations.
Over the past two years, the Covid pandemic has resulted in a backlog of elective care within the NHS, with record numbers of patients on waiting lists
across the UK. Despite efforts to catch up after the first wave, subsequent waves have put further strain on an already stretched NHS system.
This has had a tremendous impact on many patients waiting for routine dermatology appointments and, while every effort has been made to see patients with suspected
serious skin cancers within two weeks, this target is not always achieved.
With rising waiting times, pharmacists are increasingly the first port of call for patients suffering with a broad range of skin problems. From acne and rosacea,
eczema or psoriasis, to changing skin lesions or simple insect bites, pharmacists can give helpful advice, allowing some customers to find quick relief to their
skin complaint in mild cases, while directing others to see their GP without delay.
Below is some practical advice that pharmacists can give to their customers with commonly encountered skin complaints.
Acne
Acne is a common skin condition that not only affects teenagers but adults too. It is estimated that up to 40 per cent of women continue to suffer with acne into
their adult years. Acne has been linked to an increased incidence of depression, anxiety and even suicidal ideation.
Patients have reported feeling overlooked and often dismissed in their concerns by health care professionals.
Unfortunately, these issues have been further compounded by delays in being seen and treated due to the ongoing Covid pandemic. Pharmacists are well placed to help
acne patients choose the right skincare. This should consist of lightweight products, such as gel or milky cleansers, with moisturisers in serum, lotion or light
cream preparations. Some acne suitable products are further labelled as non-comedogenic.
Oil-based or occlusive preparations are best avoided. There are many good quality, non-comedogenic sun blocks suited
In its response to the Health and Social Care Committee inquiry into 'Digital Transformation in the NHS', the Community Pharmacy IT Group (CP ITG) has
highlighted issues concerning the NHS community pharmacy.
CP ITG, of which PSNC is a member, has urged that pharmacy teams should have access to up-to-date records information, e.g. from Shared Care Records, GP Connect
and Summary Care Records with Additional Information.
It has also stated that the Booking and Referral Standards (BaRS) should be extended so that future referrals into and from pharmacy can be communicated seamlessly.
In its written response, CP ITG said: "Ensure that BaRS is expanded and aligns with other referral IT standards such as GP Connect referrals. Ensure it is used across
community pharmacy, the GP sector, other health care sectors and across the NHS, and by all health IT suppliers, so that messages and referrals can flow smoothly
within and across sectors and patients can have a seamless experience and safe care."
The group has asked the Health and Social Care Committee to create a framework for the development of pharmacy IT to ensure IT suppliers are better equipped to
support pharmacy teams and their delivery of services.
The Pharmaceutical Services Negotiating Committee (PSNC) has been reminding contractors to complete the 2022/23 Community Pharmacy Assurance Framework (CPAF)
screening questionnaire by midnight on Wednesday, 31 August 2022.
As a result of NHS regulations introduced at the end of 2020, completion of CPAF is now a requirement of the Terms of Service. "Therefore, contractors must complete
the screening questionnaire and, if required, the full CPAF questionnaire," said PSNC.
It has also recommended that any contractor who has yet to do so takes immediate action. "It should only take approximately 10-20 minutes to complete."
Information and instructions on how to complete the screening questionnaire has been shared either via an email from the NHS Business Services Authority (NHSBSA) or
from their own Head Office.
Contractors are advised to contact NHSBSA by emailing nhsbsa.cpaf@nhs.net if they have not received details of the questionnaire, or if they have any problems or
queries completing the questionnaire.